Alcohol Sensitivity Among Older Adults Who Consume Alcohol
Individual Differences in Alcohol Sensitivity
1 other identifier
interventional
80
1 country
1
Brief Summary
This is a proof-of-concept study exploring individual differences in sensitivity to alcohol among older healthy current drinkers aged 65 to 80. Participants will complete two sessions during which they will complete questionnaires and laboratory measures of mental abilities and brain activity and receive a beverage that may or may not contain a moderate dose of alcohol.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 26, 2026
CompletedFirst Posted
Study publicly available on registry
June 9, 2026
CompletedStudy Start
First participant enrolled
July 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2028
Study Completion
Last participant's last visit for all outcomes
June 1, 2028
June 9, 2026
May 1, 2026
1.9 years
May 26, 2026
June 3, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Alcohol Effects on Psychomotor Skills as reflected in the Trail Making Test (TMT)
Difference between the number of seconds required to complete the TMT under placebo vs the alcohol condition for each individual
The placebo and alcohol sessions occur ~ 10-14 days apart.
Alcohol Effects on a Working Memory Task requiring Continuous Recognition
Differences in accuracy in identifying previously seen vs. new items a working memory task under alcohol vs placebo conditions for each individual
The placebo and alcohol sessions occur ~ 10-14 days apart.
Alcohol Effects on Neural Activity Measured from Scalp Electroencephalography
Differences in neural activity as reflected obtained through non-invasive electroencephalography under alcohol vs placebo conditions for each individual
The alcohol and placebo sessions occur ~ 10-14 days apart.
Secondary Outcomes (1)
Correlation between alcohol sensitivity and standard cognitive assessment
The general measure of cognitive abilities is obtained in the first session, prior to the experimental condition. The difference scores are derived by comparing outcomes between alcohol vs placebo sessions which are ~ 10-14 days apart.
Study Arms (2)
Alcohol Condition
EXPERIMENTALBeverage contains an alcohol volume consistent with achieving a sub-intoxicating breath alcohol concentration
Non-Alcohol Session
PLACEBO COMPARATORPlacebo beverage is administered
Interventions
on each of two visits, participants receive either the placebo drink or the drinking containing alcohol
Eligibility Criteria
You may qualify if:
- Alcohol Drinkers who consume alcohol on a regular basis
- No history of significant substance misuse
You may not qualify if:
- current Cigarette smoker
- Type 1 Diabetes or uncontrolled Type 2 Diabetes
- Epilepsy
- Neurodegenerative disorder
- Significant psychiatric disorder such as a psychotic disorder, bipolar disorder, current major depression or PTSD
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Florida
Gainesville, Florida, 32610, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sara Jo Nixon, PhD
University of Florida
- PRINCIPAL INVESTIGATOR
Ben Lewis, PhD
University of Florida
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 26, 2026
First Posted
June 9, 2026
Study Start (Estimated)
July 1, 2026
Primary Completion (Estimated)
June 1, 2028
Study Completion (Estimated)
June 1, 2028
Last Updated
June 9, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share
Data will be made available through an NIH repository.